BioSenic S.A.
BIOS.BR · BRU
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €0 | €543 | €296 | €312 |
| % Growth | -100% | 83.4% | -5.1% | – |
| Cost of Goods Sold | €196 | €0 | €60 | €13 |
| Gross Profit | -€196 | €543 | €296 | €987 |
| % Margin | – | 100% | 100% | 316.3% |
| R&D Expenses | €2,207 | €3,741 | €1,030 | €619 |
| G&A Expenses | €0 | €3,651 | €619 | €1,768 |
| SG&A Expenses | €5,869 | €3,607 | €1,554 | €557 |
| Sales & Mktg Exp. | €0 | -€44 | €0 | €0 |
| Other Operating Expenses | €0 | €28 | -€60 | €0 |
| Operating Expenses | €8,076 | €7,376 | €2,524 | €1,176 |
| Operating Income | -€8,272 | -€7,040 | -€2,318 | -€1,189 |
| % Margin | – | -1,296.5% | -783.1% | -381.1% |
| Other Income/Exp. Net | €1,563 | -€21,988 | -€731 | €205 |
| Pre-Tax Income | -€6,709 | -€29,028 | -€3,049 | -€984 |
| Tax Expense | €0 | -€7 | €0 | €89 |
| Net Income | -€4,768 | -€28,778 | -€2,041 | -€984 |
| % Margin | – | -5,299.8% | -689.5% | -315.4% |
| EPS | -0.021 | -0.21 | -0.017 | -0.046 |
| % Growth | 90.2% | -1,135.3% | 63.2% | – |
| EPS Diluted | -0.021 | -0.21 | -0.017 | -0.046 |
| Weighted Avg Shares Out | 231,336 | 137,038 | 120,132 | 21,311 |
| Weighted Avg Shares Out Dil | 231,336 | 137,038 | 120,132 | 21,311 |
| Supplemental Information | – | – | – | – |
| Interest Income | €57 | €59 | €3 | €0 |
| Interest Expense | €1,677 | €5,954 | €278 | €107 |
| Depreciation & Amortization | €196 | €234 | €60 | €13 |
| EBITDA | -€4,836 | -€6,796 | -€2,258 | -€864 |
| % Margin | – | -1,251.6% | -762.8% | -276.9% |